V. Feillel
- Cancer Research top 5%
- Breast Cancer Treatment Studies 12
- Oncology top 5%
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 3
-
- Breast Lesions and Carcinomas 11
- Lymphoma Diagnosis and Treatment 3
-
- Radiopharmaceutical Chemistry and Applications 2
-
- BRCA gene mutations in cancer 2
-
- Breast Implant and Reconstruction 3
V. Feillel
25 papers receiving 865 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 449
- Oncology 515
- Pathology and Forensic Medicine 245
- Radiology, Nuclear Medicine and Imaging 174
- Genetics 112
Countries citing papers authored by V. Feillel
This map shows the geographic impact of V. Feillel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Feillel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Feillel more than expected).
Fields of papers citing papers by V. Feillel
This network shows the impact of papers produced by V. Feillel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Feillel. The network helps show where V. Feillel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside V. Feillel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2018 | 0 | |
| 3 | 2008 | 54 | |
| 4 | 2005 | 7 | |
| 5 | 2005 | 29 | |
| 6 | 2004 | 11 | |
| 7 | 2004 | 10 | |
| 8 | 2004 | 1 | |
| 9 | 2003 | 64 | |
| 10 | 2002 | 54 | |
| 11 | 2002 | 32 | |
| 12 | 2002 | 19 | |
| 13 | 2000 | 1 | |
| 14 | 1998 | 3 | |
| 15 | 1997 | 92 | |
| 16 | [Mastectomy with immediate reconstruction for invasive breast cancer. Comments on indications and technique. A series of 112 cases]. | 1996 | 3 |
| 17 | Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes. | 1996 | 92 |
| 18 | 1993 | 40 | |
| 19 | 1991 | 179 | |
| 20 | 1990 | 3 |
About V. Feillel
V. Feillel is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Genetics and Biophysics, having authored 26 papers that have together received 894 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (11 papers), Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Breast Implant and Reconstruction (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Cancer Research (449 citations), Oncology (515 citations), Pathology and Forensic Medicine (245 citations), Radiology, Nuclear Medicine and Imaging (174 citations) and Genetics (112 citations). V. Feillel has collaborated with scholars based in France. Frequent co-authors include P. Chollet, G. Le Bouëdec, J Dauplat, Fabrice Kwiatkowski, Pierre Verrelle, M de Latour, Jean-Pierre Ferrière, J Chassagne, H. Curé and Frédérique Penault‐Llorca. Their work appears in journals such as European Journal of Cancer, International Journal of Oncology, Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and International Journal of Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.